Brigatinib Tablets (Alunbrig)

    loading  Checking for direct PDF access through Ovid

Abstract

Brigatinib is indicated for the treatment of patients with anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.

Related Topics

    loading  Loading Related Articles